GBIO Generation Bio Co
Price (delayed)
$2.64
Market cap
$176.2M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.39
Enterprise value
$239.5M
Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent
Highlights
The gross profit has grown by 32% from the previous quarter
GBIO's revenue is up by 32% since the previous quarter
The net income has contracted by 25% YoY but it has grown by 6% from the previous quarter
Generation Bio's debt has increased by 17% YoY but it has decreased by 2.1% from the previous quarter
The equity has shrunk by 55% YoY and by 13% QoQ
The quick ratio has contracted by 39% YoY and by 6% from the previous quarter
Key stats
What are the main financial stats of GBIO
Market
Valuations
Earnings
Shares outstanding
66.74M
Market cap
$176.2M
Enterprise value
$239.5M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.52
Price to sales (P/S)
13.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.18
Revenue
$13.17M
EBIT
-$158.43M
EBITDA
-$153.23M
Free cash flow
-$110.12M
Per share
Balance sheet
Liquidity
EPS
-$2.39
Free cash flow per share
-$1.66
Book value per share
$1.73
Revenue per share
$0.2
TBVPS
$3.99
Total assets
$265.26M
Total liabilities
$149.86M
Debt
$93.96M
Equity
$115.41M
Working capital
$193.18M
Debt to equity
0.81
Current ratio
7.42
Quick ratio
7.32
Net debt/EBITDA
-0.41
Margins
Efficiency
Dividend
EBITDA margin
-1,163.1%
Gross margin
100%
Net margin
-1,202.6%
Operating margin
-1,295.9%
Return on assets
-48.5%
Return on equity
-92.9%
Return on invested capital
-48.6%
Return on capital employed
-67.4%
Return on sales
-1,202.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GBIO stock price
How has the Generation Bio stock price performed over time
Intraday
0%
1 week
8.2%
1 month
5.6%
1 year
-34.65%
YTD
60%
QTD
-6.38%
Financial performance
How have Generation Bio's revenue and profit performed over time
Revenue
$13.17M
Gross profit
$13.17M
Operating income
-$170.72M
Net income
-$158.43M
Gross margin
100%
Net margin
-1,202.6%
GBIO's operating margin has surged by 92% year-on-year and by 29% since the previous quarter
Generation Bio's net margin has soared by 92% YoY and by 29% from the previous quarter
The gross profit has grown by 32% from the previous quarter
GBIO's revenue is up by 32% since the previous quarter
Growth
What is Generation Bio's growth rate over time
Valuation
What is Generation Bio stock price valuation
P/E
N/A
P/B
1.52
P/S
13.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.18
Generation Bio's EPS has decreased by 15% YoY but it has increased by 6% from the previous quarter
The equity has shrunk by 55% YoY and by 13% QoQ
The P/B is 28% below the 5-year quarterly average of 2.1 but 17% above the last 4 quarters average of 1.3
GBIO's price to sales (P/S) is 62% lower than its last 4 quarters average of 35.5
GBIO's revenue is up by 32% since the previous quarter
Efficiency
How efficient is Generation Bio business performance
Generation Bio's ROE has plunged by 106% YoY and by 13% from the previous quarter
Generation Bio's ROS has soared by 92% YoY and by 29% from the previous quarter
The ROA has plunged by 54% YoY and by 3.9% from the previous quarter
Generation Bio's ROIC has decreased by 31% YoY but it has increased by 6% from the previous quarter
Dividends
What is GBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GBIO.
Financial health
How did Generation Bio financials performed over time
Generation Bio's total assets is 77% higher than its total liabilities
The quick ratio has contracted by 39% YoY and by 6% from the previous quarter
The current ratio is down by 39% year-on-year and by 7% since the previous quarter
Generation Bio's debt is 19% less than its equity
Generation Bio's debt to equity has surged by 153% YoY and by 11% QoQ
The equity has shrunk by 55% YoY and by 13% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.